The effect of continuous subcutaneous apomorphine infusion on vitamin B metabolites and plasma homocysteine in Parkinson’s disease patients
Objective: To evaluate the plasma level of vitamin B and homocysteine between PD patients with conventional medications and PD patients with CSAI. Background: Although levodopa…Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study
Objective: To investigate the complementary effects of a standardized Osteopathic Manipulative Treatment (OMT) Protocol on sleep quality using the Pittsburgh Sleep Index (PSQI) Background: Parkinson’s…Concordant RNA patterns in Parkinson’s disease brain and peripheral blood.
Objective: To investigate the molecular correlates of clinical heterogeneity in Parkinson’s disease (PD) in the striatum and peripheral blood. Background: The molecular basis for clinical…Transforming Parkinson’s Care in Africa: community engagement and involvement activities
Objective: To outline the role of community engagement and involvement (CEI) in global health research to support people with Parkinson’s and their caregivers across Africa.…PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)
Objective: Describe the relative frequency of bothersome cognitive symptoms reported verbatim by people with PD in the Fox Insight online study. Background: Cognitive decline is…Loneliness, Self-Efficacy, and Resilience: Neglected Modifiable Contributors to Parkinson’s Disease Symptom Severity and Quality of Life
Objective: To evaluate the degree to which modifiable psychosocial (PS) variables including loneliness, self-efficacy (SE) and resilience explain the variance observed in Parkinson’s disease (PD)…GBA p.K198E mutation causing Parkinson Disease in Colombian population: the first clinical description
Objective: Describe the main clinical features of three subjects with inherited Parkinson's disease (PD) due to glucocerebrosidase (GBA) p.K198E substitution. Background: Recessive mutation of the…Movement-related modulation of beta/high frequency oscillations and low-beta pallido-cortical coherence in Parkinson’s disease.
Objective: To characterize changes in synchronized oscillatory activity and coherence between the globus pallidus (GPi) and primary motor cortex (M1) of Parkinson’s disease (PD) patients…Neurologic dysfunction assessment in Parkinson’s disease based on fundus photographs using deep learning
Objective: To develop an algorithm that can predict Hoehn and Yahr (H–Y) and Unified Parkinson's Disease Rating Scale part III (UPDRS-III) scores using fundus photography among…Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease
Objective: To report the efficacy and safety profiles of patients on sustained foslevodopa/foscarbidopa (LDP/CDP) continuous subcutaneous infusion (CSCI) mono- or polytherapy from three phase 3…
- « Previous Page
- 1
- …
- 245
- 246
- 247
- 248
- 249
- …
- 436
- Next Page »